Abdulaziz Radhi S Aljohni¹*, Tawfeek Rezeek Almotiri², Tariq Ibrahim Alhazmy³, Ghazi Khalil Suliman Alqouzi⁴ and Fahd Omar AL Mhmodi⁵ 

¹Phd Microbiology, Department of Laboratory at King Fahad Hospital, Medina, Saudi Arabia

*Corresponding Author: Abdulaziz Radhi S Aljohni, Phd Microbiology, Department of Laboratory at King Fahad Hospital, Medina, Saudi Arabia.

Received: November 12, 2021 ; Published: November 29, 2021

Abstract

STEC generates Shiga-toxins, named after Shigella dysenteriae toxins. STEC grows well in temperatures between 7 to 50°C, with an optimum of 37°C. Some STEC may grow in acidic meals with pH as low as 4.4 and water activity (aW) as low as 0.95.

STEC is eradicated by thoroughly heating meals to 70°C or above. The most common STEC serotype is E. coli O157:H7, however other serotypes have been implicated in occasional cases and outbreaks.

Keywords: Escherichia coli; Commonly Found Humans; Warm-blooded Animals; Taxonomy; Symptoms; Treatment

References

1. Riley LW., et al. “Hemorrhagic colitis associated with a rare Escherichia coli serotype ”. The New England Journal of Medicine 308 (1983): 681-685.
2. Levine MM and Edelman R. “Enteropathogenic Escherichia coli of classic serotypes associated with infant diarrhea: epidemiology and pathogenesis”. Epidemiologic Reviews 6 (1984): 31-51.
3. Gasser C., et al. “Hamolytischuramische syndrome: Bilaterale nierenrindennekrosen bei akuten erworbenen hamolytischen anamien”. Schweizerische Medizinische Wochenschrift 85 (1955): 205-9.
4. Evans AS. “Epidemiologic concepts”. In: Evans AS, Brachman PS, eds. Bacterial infections of humans: epidemiology and control. 2nd ed. New York: Plenum Medical Book Company (1991): 3-57.
5. Riley LW. “The epidemiologic, clinical, and microbiologic features of hemorrhagic colitis”. Annual Review of Microbiology 41 (1987): 383-407.
6. Karmali MA. “Infection by verocytotoxin producing Escherichia coli”. Clinical Microbiology Reviews 2 (1989): 15-38.
7. Griffin PM., et al. “Illnesses associated with Escherichia coli O157:H7 infections”. A broad Clinical Spectrum Annals of Internal Medicine 109 (1988): 705-712.
8. O'Brien AD and Holmes RK. “Shiga-like toxins”. Microbiology and Molecular Biology Reviews 2 (1987): 206-220.
9. JG Holt., et al. “Facultatively Gram-Negative Rods”. Subgroup 1. Family Enterobacteriaceae. Determinative Bacteriology, 9th-edition, Williams, and Wilkins (1994): 175-189.
10. Huang DB., et al. “Enteroaggregative Escherichia coli: an emerging enteric pathogen”. The American Journal of Gastroenterology 2010 (2010):
11. Glandt M., et al. “Enteroaggregative Escherichia coli as a cause of traveler’s diarrhea: clinical response to ciprofloxacin”. Clinical Infectious Diseases 29 (1999): 335-338.
12. Sobieszczanska B., et al. “Susceptibility to antimicrobial agents of enteroaggregative Escherichia coli strains isolated from children with diarrhea”. Epidemiologic Reviews 57 (2003): 499-503.
13. Yamamoto T., et al. “Drug resistance and adherence to human intestines of enteroaggregative Escherichia coli”. The Journal of Infectious Diseases 165 (1992): 744-749.
14. Infante RM., et al. “Enteroaggregative Escherichia coli diarrhea in travelers: response to rifaximin therapy”. Clinical Gastroenterology and Hepatology 2 (2004): 135-138.
15. Nagy B and Fekete PZ. “Enterotoxigenic Escherichia coli in veterinary medicine”. International Journal of Medical Microbiology 295 (2005): 443-454.
16. Sarantuya J., et al. “Typical enteroaggregative Escherichia coli is the most prevalent pathotype among E. coli strains causing diarrhea in Mongolian children”. Journal of Clinical Microbiology 42 (2004): 133-139.
17. Dutta S., et al. “Use of PCR to identify enteroaggregative Escherichia coli as an important cause of acute diarrhoea among children living in Calcutta, India”. Journal of Medical Microbiology 48 (1999): 1011-1016.
18. Wanke CA., et al. “Enteroaggregative Escherichia coli as a potential cause of diarrheal disease in adults infected with human immunodeficiency virus”. The Journal of Infectious Diseases 178 (1998): 185-190.
19. Bielaszewska M., et al. “Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study”. The Lancet Infectious Diseases 11 (2011): 671-676.
20. EHEC/HUS O104:H4 -The outbreak is over. Robert Koch Institute (2011).
21. Mellmann A., et al. “Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli”. Emerging Infectious Diseases 2008 14 (2008): 1287-1290.
22. Bae WK., et al. “A case of hemolytic uremic syndrome caused by Escherichia coli O104:H4”. Yonsei Medical Journal 47 (2006): 437.
23. Snelling AM., et al. “The commonly-used DNA probe for diffusely-adherent Escherichia coli cross-reacts with a subset of enteroaggregative E. coli”. BMC Microbiology 9 (2009): 269.
24. Gunzburg ST., et al. “Diffuse and enteroaggregative patterns of adherence of enteric Escherichia coli isolated from aboriginal children from the Kimberley region of Western Australia”. The Journal of Infectious Diseases 167 (1993): 755-758.
25. Scaletsky IC., et al. “Diffusely adherent Escherichia coli as a cause of acute diarrhea in young children in Northeast Brazil: a case-control study”. Journal of Clinical Microbiology 40 (2002): 645-648.
26. Darfeuille-Michaud A., et al. “High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease”. Gastroenterology 127 (2004): 412-421.
27. Rolhion N and Darfeuille-Michaud A. “Adherent-invasive Escherichia coli in inflammatory bowel disease”. Inflammatory Bowel Diseases 13 (2007): 1277-1283.
28. Scallan E., et al. “Foodborne illness acquired in the United States”. Emerging Infectious Diseases 17 (2011): 1339-1340.
29. Barton Behravesh C., et al. FoodNet Working Group. “Deaths associated with bacterial pathogens transmitted commonly through food: foodborne diseases active surveillance network (FoodNet), 1996-2005”. The Journal of Infectious Diseases 204 (2011): 263-267.
30. European Food Safety Authority. “The European Union Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-borne Outbreaks in 2009”. EFSA Journal 9 (2011): 2090-2468.
31. Gärtner JF and Schmidt MA. “Comparative analysis of locus of enterocyte effacement pathogenicity islands of atypical enteropathogenic Escherichia coli”. Infection and Immunity11 (2004): 6722-6728.
32. Ingle DJ., et al. “Evolution of atypical enteropathogenic E. coli by repeated acquisition of LEE pathogenicity island variants”. Nature Microbiology 1 (2016): 15010.
33. Rocha LB., et al. “Interaction between Shiga toxin and monoclonal antibodies: binding characteristics and in vitro neutralizing abilities”. Toxins 4 (2012): 729-747.
34. Luz D., et al. “Development and characterization of recombinant antibody fragments that recognize and neutralize in vitro stx2 toxin from Shiga toxin-producing Escherichia coli”. PLoS One3 (2015): 0120481.
35. L Hannah Gould., et al. Center of Disease Control of United States, Centers for Disease Control and Prevention. “Recommendations for diagnosis of Shiga toxin-producing Escherichia coli infections by clinical laboratories”. Morbidity and Mortality Weekly Report 58 (2009): 1-12.

Citation

Citation: Abdulaziz Radhi S Aljohni., et al. “New Perspectives on Enteric Pathogenic Bacteria Bacterium Escherichia coli". Acta Scientific Microbiology 4.12 (2021): 111-118.

Copyright

Copyright: © 2021 Abdulaziz Radhi S Aljohni., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.